HCPCS Level II · Drugs administered other than oral method
J7169Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J7169
J7169 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg.
It was added to HCPCS effective 07/01/2020.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj andexxa, 10 mg
- Date added
- 07/01/2020
- Action effective
- 07/01/2020
- BETOS
- O1E
Related J71xx codes
- J7100Infusion, dextran 40, 500 ml
- J7110Infusion, dextran 75, 500 ml
- J7120Ringers lactate infusion, up to 1000 cc
- J71215% dextrose in lactated ringers infusion, up to 1000 cc
- J7131Hypertonic saline solution, 1 ml
- J7165Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- J7170Injection, emicizumab-kxwh, 0.5 mg
- J7171Injection, adamts13, recombinant-krhn, 10 iu
- J7172Injection, marstacimab-hncq, 0.5 mg
- J7173Injection, concizumab-mtci, 0.5 mg
- J7174Injection, fitusiran, 0.04 mg
Common questions about J7169
Is HCPCS J7169 still valid?
- Yes. J7169 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J7169?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.